AVP and Hyponatremia: After all, it is dopamine and its agonists used in the treatment of RLS that can potentiate the secretion of antidiuretic hormone (acting via aminobutyric acid and dopamine receptors in the suprachiasmatic nucleus), thereby causing the syndrome of inappropriate antidiuretic hormone secretion causing hyponatremia [50].